Trial · NCT00312377
Adverse events590
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 590
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Neutropenia | Blood and lymphatic system disorders | Vandetanib 100 mg Plus Docetaxel | 212 | 694 | |
| other | Neutropenia | Blood and lymphatic system disorders | Placebo Plus Docetaxel | 174 | 697 | |
| other | Leukopenia | Blood and lymphatic system disorders | Vandetanib 100 mg Plus Docetaxel | 125 | 694 | |
| other | Leukopenia | Blood and lymphatic system disorders | Placebo Plus Docetaxel | 106 | 697 | |
| other | Anaemia | Blood and lymphatic system disorders | Vandetanib 100 mg Plus Docetaxel | 68 | 694 | |
| other | Anaemia | Blood and lymphatic system disorders | Placebo Plus Docetaxel | 98 | 697 | |
| other | Diarrhoea | Gastrointestinal disorders | Vandetanib 100 mg Plus Docetaxel | 284 | 694 | |
| other | Diarrhoea | Gastrointestinal disorders | Placebo Plus Docetaxel | 218 | 697 | |
| other | Nausea | Gastrointestinal disorders | Vandetanib 100 mg Plus Docetaxel | 158 | 694 | |
| other | Nausea | Gastrointestinal disorders | Placebo Plus Docetaxel | 221 | 697 | |
| other | Vomiting | Gastrointestinal disorders | Vandetanib 100 mg Plus Docetaxel | 105 | 694 | |
| other | Vomiting | Gastrointestinal disorders | Placebo Plus Docetaxel | 141 | 697 | |
| other | Constipation | Gastrointestinal disorders | Vandetanib 100 mg Plus Docetaxel | 119 | 694 | |
| other | Constipation | Gastrointestinal disorders | Placebo Plus Docetaxel | 140 | 697 | |
| other | Stomatitis | Gastrointestinal disorders | Vandetanib 100 mg Plus Docetaxel | 80 | 694 | |
| other | Stomatitis | Gastrointestinal disorders | Placebo Plus Docetaxel | 80 | 697 | |
| other | Abdominal Pain | Gastrointestinal disorders | Vandetanib 100 mg Plus Docetaxel | 41 | 694 | |
| other | Abdominal Pain | Gastrointestinal disorders | Placebo Plus Docetaxel | 50 | 697 | |
| other | Dyspepsia | Gastrointestinal disorders | Vandetanib 100 mg Plus Docetaxel | 37 | 694 | |
| other | Dyspepsia | Gastrointestinal disorders | Placebo Plus Docetaxel | 25 | 697 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00312377/events